Back
Microsoft Vs. Blueprint Medicines Sector Stock Comparison
Buy
64
MSFT
Microsoft
Last Price:
$485.90
Seasonality Move:
1.98%
Buy
52
BPMC
Blueprint Medicines
Last Price:
$128.43
Seasonality Move:
10.35%
Buy
52
Blueprint Medicines (BPMC)
is a Buy
Is Blueprint Medicines a Buy, Sell or Hold?
-
The current Blueprint Medicines [BPMC] share price is $128.20. The Score for BPMC is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
-
BPMC is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
BPMC Stock Price Chart
What is Blueprint Medicines's stock price today?
-
The Blueprint Medicines share price today is $128.20Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BPMC is experiencing slight buying pressure.
MSFT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 11.53 | Buy |
Relative Strength Index (14 RSI): | 68.96 | Buy |
Chaikin Money Flow: | -31532082 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (455.85 - 474.63) | Buy |
Bollinger Bands (100): | (380.64 - 450.96) | Buy |
BPMC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 7.7 | Buy |
Relative Strength Index (14 RSI): | 75.62 | Buy |
Chaikin Money Flow: | 1502050 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (102.43 - 129.61) | Buy |
Bollinger Bands (100): | (85.02 - 113.84) | Buy |
MSFT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 476.52 | Buy |
20-day SMA: | 467.7 | Buy |
50-day SMA: | 435.12 | Buy |
200-day SMA: | 420.87 | Buy |
8-day EMA: | 476 | Buy |
20-day EMA: | 467.03 | Buy |
50-day EMA: | 444.9 | Buy |
200-day EMA: | 421.38 | Buy |
BPMC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 128.11 | Buy |
20-day SMA: | 119.69 | Buy |
50-day SMA: | 103.32 | Buy |
200-day SMA: | 95.92 | Buy |
8-day EMA: | 127.3 | Buy |
20-day EMA: | 120.82 | Buy |
50-day EMA: | 109.36 | Buy |
200-day EMA: | 98.18 | Buy |
Microsoft Earnings Growth & MSFT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.60 per share, an increase next quarter of $0.06 per share, an increase this year of $1.57 per share, and an increase next year of $1.71 per share.
Blueprint Medicines Earnings Growth & BPMC Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.67 per share, an increase next quarter of $0.33 per share, an increase this year of $0.60 per share, and an increase next year of $1.50 per share.
Microsoft Technical Analysis
Jun 6 | Jun 9 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 16 | Jun 17 | Jun 18 | Jun 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Blueprint Medicines Technical Analysis
Jun 6 | Jun 9 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 16 | Jun 17 | Jun 18 | Jun 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |